|
CLCN4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.644600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.622400E-01 |
| Normal-vs-Stage2 |
9.422000E-01 |
| Normal-vs-Stage3 |
6.517600E-02 |
| Normal-vs-Stage4 |
5.439800E-01 |
| Stage1-vs-Stage2 |
7.993000E-01 |
| Stage1-vs-Stage3 |
4.150100E-02 |
| Stage1-vs-Stage4 |
6.483400E-01 |
| Stage2-vs-Stage3 |
7.662500E-02 |
| Stage2-vs-Stage4 |
5.267000E-01 |
| Stage3-vs-Stage4 |
1.381770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.785400E-01 |
| Normal-vs-AfricanAmerican |
2.359200E-01 |
| Normal-vs-Asian |
8.096200E-01 |
| Caucasian-vs-AfricanAmerican |
1.185400E-01 |
| Caucasian-vs-Asian |
7.542800E-01 |
| AfricanAmerican-vs-Asian |
9.583200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.469400E-01 |
| Normal-vs-Female |
1.006550E-01 |
| Male-vs-Female |
2.833600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.921600E-01 |
| Normal-vs-Extreme_Weight |
7.942200E-02 |
| Normal-vs-Obese |
4.857600E-01 |
| Normal-vs-Extreme_Obese |
9.286000E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.389900E-02 |
| Normal_Weight-vs-Obese |
7.094000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.748200E-01 |
| Extreme_Weight-vs-Obese |
4.633900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.350000E-01 |
| Obese-vs-Extreme_Obese |
6.979200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.324600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.585700E-02 |
| Normal-vs-Age(61-80Yrs) |
1.135220E-01 |
| Normal-vs-Age(81-100Yrs) |
6.439800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.275600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.952800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.006600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.540900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.131000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.376600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.130100E-02 |
| Normal-VS-Type2 PRCC |
3.861300E-03 |
| Normal-VS-KIRP CIMP |
1.079980E-03 |
| Normal-VS-Unclassified PRCC |
1.594600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.191990E-04 |
| Type1 PRCC-VS-KIRP CIMP |
3.525900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.297500E-03 |
| Type2 PRCC-VS-KIRP CIMP |
2.397500E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.445830E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.484900E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.843400E-01 |
| Normal-vs-N1 |
4.796800E-01 |
| Normal-vs-N2 |
3.811200E-01 |
| N0-vs-N1 |
8.801000E-01 |
| N0-vs-N2 |
4.822400E-01 |
| N1-vs-N2 |
5.984600E-01 |
|
|
